Cargando…

Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation

The fast elimination of drugs from the cornea is one of many challenges associated with the topical administration of conventional dosage forms. The present manuscript aimed to prepare modified-release inserts containing erythromycin (ERY) to enhance drug delivery and address the aforementioned limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaeei, Shahla, Taghe, Shiva, Alany, Raid G., Nokhodchi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405482/
https://www.ncbi.nlm.nih.gov/pubmed/36009463
http://dx.doi.org/10.3390/biomedicines10081917
_version_ 1784773891503161344
author Mirzaeei, Shahla
Taghe, Shiva
Alany, Raid G.
Nokhodchi, Ali
author_facet Mirzaeei, Shahla
Taghe, Shiva
Alany, Raid G.
Nokhodchi, Ali
author_sort Mirzaeei, Shahla
collection PubMed
description The fast elimination of drugs from the cornea is one of many challenges associated with the topical administration of conventional dosage forms. The present manuscript aimed to prepare modified-release inserts containing erythromycin (ERY) to enhance drug delivery and address the aforementioned limitation. Film formulations were developed using Eudragit(®) L100 (EUD) and Polyvinyl Alcohol (PVA) polymers. ERY-loaded EUD-based nanoparticles were developed by the colloidal dispersion method using PVA as the emulsifier. The film-casting method was applied to form the mucoadhesive films using sodium alginate, gelatin, cyclodextrin-α, and β as polymeric film matrices. Different physicochemical properties of the optimized formulations and in vitro release profiles were evaluated. The in vivo evaluation was performed by collecting tear samples of rabbits using a novel, non-invasive method following the administration of inserts in the cul-de-sac. The ERY amount was assayed using a microbiological assay. The developed films showed prolonged in vitro and in vivo release profiles over five to six days; they had suitable physicochemical properties and a tensile strength of 2–3 MPa. All formulations exhibited antibacterial efficacy against E. coli and S. aureus with more than 20 mm diameter of inhibited growth zones. None of the formulations caused irritation to the rabbit’s eye. The inserts showed promising pharmacokinetics with AUC(0–120) of 30,000–36,000 µg·h/mL, a C(max) of more than 1800 µg/mL at 4 h, and maintained drug concentration over the threshold of 5 µg/mL during the following 120 h of study. Nanoparticle-containing, mucoadhesive films could be fabricated as ocular inserts and can prolong the topical ocular delivery of ERY.
format Online
Article
Text
id pubmed-9405482
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94054822022-08-26 Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation Mirzaeei, Shahla Taghe, Shiva Alany, Raid G. Nokhodchi, Ali Biomedicines Article The fast elimination of drugs from the cornea is one of many challenges associated with the topical administration of conventional dosage forms. The present manuscript aimed to prepare modified-release inserts containing erythromycin (ERY) to enhance drug delivery and address the aforementioned limitation. Film formulations were developed using Eudragit(®) L100 (EUD) and Polyvinyl Alcohol (PVA) polymers. ERY-loaded EUD-based nanoparticles were developed by the colloidal dispersion method using PVA as the emulsifier. The film-casting method was applied to form the mucoadhesive films using sodium alginate, gelatin, cyclodextrin-α, and β as polymeric film matrices. Different physicochemical properties of the optimized formulations and in vitro release profiles were evaluated. The in vivo evaluation was performed by collecting tear samples of rabbits using a novel, non-invasive method following the administration of inserts in the cul-de-sac. The ERY amount was assayed using a microbiological assay. The developed films showed prolonged in vitro and in vivo release profiles over five to six days; they had suitable physicochemical properties and a tensile strength of 2–3 MPa. All formulations exhibited antibacterial efficacy against E. coli and S. aureus with more than 20 mm diameter of inhibited growth zones. None of the formulations caused irritation to the rabbit’s eye. The inserts showed promising pharmacokinetics with AUC(0–120) of 30,000–36,000 µg·h/mL, a C(max) of more than 1800 µg/mL at 4 h, and maintained drug concentration over the threshold of 5 µg/mL during the following 120 h of study. Nanoparticle-containing, mucoadhesive films could be fabricated as ocular inserts and can prolong the topical ocular delivery of ERY. MDPI 2022-08-08 /pmc/articles/PMC9405482/ /pubmed/36009463 http://dx.doi.org/10.3390/biomedicines10081917 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mirzaeei, Shahla
Taghe, Shiva
Alany, Raid G.
Nokhodchi, Ali
Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title_full Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title_fullStr Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title_full_unstemmed Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title_short Eudragit(®) L100/Polyvinyl Alcohol Nanoparticles Impregnated Mucoadhesive Films as Ocular Inserts for Controlled Delivery of Erythromycin: Development, Characterization and In Vivo Evaluation
title_sort eudragit(®) l100/polyvinyl alcohol nanoparticles impregnated mucoadhesive films as ocular inserts for controlled delivery of erythromycin: development, characterization and in vivo evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405482/
https://www.ncbi.nlm.nih.gov/pubmed/36009463
http://dx.doi.org/10.3390/biomedicines10081917
work_keys_str_mv AT mirzaeeishahla eudragitl100polyvinylalcoholnanoparticlesimpregnatedmucoadhesivefilmsasocularinsertsforcontrolleddeliveryoferythromycindevelopmentcharacterizationandinvivoevaluation
AT tagheshiva eudragitl100polyvinylalcoholnanoparticlesimpregnatedmucoadhesivefilmsasocularinsertsforcontrolleddeliveryoferythromycindevelopmentcharacterizationandinvivoevaluation
AT alanyraidg eudragitl100polyvinylalcoholnanoparticlesimpregnatedmucoadhesivefilmsasocularinsertsforcontrolleddeliveryoferythromycindevelopmentcharacterizationandinvivoevaluation
AT nokhodchiali eudragitl100polyvinylalcoholnanoparticlesimpregnatedmucoadhesivefilmsasocularinsertsforcontrolleddeliveryoferythromycindevelopmentcharacterizationandinvivoevaluation